… but has to wait until 22 February 2022. In other words, uncertainty remains for the next 111 days before getting more details about FRE25, the transformation programme. Despite Fresenius CEO’s more friendly words about FMC’s management, we still believe not everything has been resolved in the meantime.
Q3 figures broadly meet consensus (top line: -1%; EBIT: matched; net profit: +3.0%), but the pick-up in excess mortality and the consumables raise some concern regarding profitability.
03 Nov 2021
FMC wants to break free …
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FMC wants to break free …
Fresenius Medical Care AG (FME:ETR) | 0 0 0.0%
- Published:
03 Nov 2021 -
Author:
Martin Schnee -
Pages:
5
… but has to wait until 22 February 2022. In other words, uncertainty remains for the next 111 days before getting more details about FRE25, the transformation programme. Despite Fresenius CEO’s more friendly words about FMC’s management, we still believe not everything has been resolved in the meantime.
Q3 figures broadly meet consensus (top line: -1%; EBIT: matched; net profit: +3.0%), but the pick-up in excess mortality and the consumables raise some concern regarding profitability.